BusinessAstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat Sridhar PJuly 22, 202501 mins The British drug maker plans to invest $50 billion in the United States as it seeks to appease President Trump. Post navigation Previous: 5 men’s college basketball freshmen poised to shine in mid-major conferencesNext: bitchy | Mail: Duchess Meghan is a ‘fraud’ who is only pretending to enjoy making jam! Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
IBM is the latest AI casualty. Shares are tanking 11% on Anthropic programming language threat February 24, 2026February 24, 2026
